Emergent BioSolutions to Participate in Upcoming Investor Conferences
Emergent BioSolutions (NYSE:EBS) announced its upcoming participation in two major investor conferences. The company will present at the Wells Fargo 20th Annual Healthcare Conference on September 4, 2025, at 3:00 PM ET, and at the HCW 27th Annual Global Investment Conference on September 9, 2025, at 1:30 PM ET.
Senior management will be available for one-on-one meetings at both events. Investors can access the presentations and replays through the Investors section of Emergent's website.
Emergent BioSolutions (NYSE:EBS) ha annunciato la partecipazione a due importanti conferenze per investitori. La societ脿 presenter脿 al Wells Fargo 20th Annual Healthcare Conference il 4 settembre 2025 alle 15:00 ET e al HCW 27th Annual Global Investment Conference il 9 settembre 2025 alle 13:30 ET.
I vertici aziendali saranno disponibili per incontri one-to-one in entrambe le sedi. Gli investitori potranno consultare le presentazioni e le registrazioni nella sezione Investors del sito web di Emergent.
Emergent BioSolutions (NYSE:EBS) anunci贸 su participaci贸n en dos importantes conferencias para inversores. La compa帽铆a presentar谩 en el Wells Fargo 20th Annual Healthcare Conference el 4 de septiembre de 2025 a las 15:00 ET y en el HCW 27th Annual Global Investment Conference el 9 de septiembre de 2025 a la 13:30 ET.
La alta direcci贸n estar谩 disponible para reuniones individuales en ambos eventos. Los inversores podr谩n acceder a las presentaciones y a las reproducciones desde la secci贸n Investors del sitio web de Emergent.
Emergent BioSolutions (NYSE:EBS)電� 霊� 瓿踌潣 欤检殧 韴瀽鞛� 旎嵓霟办姢鞐� 彀戈皜頃� 鞓堨爼鞚措澕瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓電� Wells Fargo 20th Annual Healthcare Conference鞐愳劀 2025雲� 9鞗� 4鞚� 鞓ろ泟 3鞁�(ET)鞐�, HCW 27th Annual Global Investment Conference鞐愳劀電� 2025雲� 9鞗� 9鞚� 鞓ろ泟 1鞁� 30攵�(ET)鞐� 氚滍憸毳� 歆勴枆頃╇媹雼�.
瓴届榿歆勳潃 霊� 頄夓偓鞐愳劀 鞚茧寑鞚� 氙疙寘鞐� 鞚戫暊 鞓堨爼鞛呺媹雼�. 韴瀽鞛愲摛鞚� Emergent 鞗轨偓鞚错姼鞚� Investors 靹轨厴鞚� 韱淀暣 氚滍憸鞛愲鞕� 鞛癌靻§潉 頇曥澑頃� 靾� 鞛堨姷雼堧嫟.
Emergent BioSolutions (NYSE:EBS) a annonc茅 sa participation 脿 deux grandes conf茅rences pour investisseurs. La soci茅t茅 pr茅sentera lors du Wells Fargo 20th Annual Healthcare Conference le 4 septembre 2025 脿 15h00 ET, et au HCW 27th Annual Global Investment Conference le 9 septembre 2025 脿 13h30 ET.
La direction g茅n茅rale sera disponible pour des rencontres individuelles lors des deux 茅v茅nements. Les investisseurs pourront consulter les pr茅sentations et les replays via la rubrique Investors du site web d'Emergent.
Emergent BioSolutions (NYSE:EBS) gab seine Teilnahme an zwei bedeutenden Investorenkonferenzen bekannt. Das Unternehmen wird am Wells Fargo 20th Annual Healthcare Conference am 4. September 2025 um 15:00 Uhr ET und am HCW 27th Annual Global Investment Conference am 9. September 2025 um 13:30 Uhr ET pr盲sentieren.
Das Senior Management steht f眉r Einzelgespr盲che auf beiden Veranstaltungen zur Verf眉gung. Investoren k枚nnen die Pr盲sentationen und Wiedergaben im Bereich Investors auf der Emergent-Website abrufen.
- None.
- None.
GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company鈥檚 senior management team will participate in the following investor conferences:
- Wells Fargo 20th Annual Healthcare Conference
September 4, 2025
3:00 pm ET
Webcast link here
One-on-one meetings
- HCW 27th Annual Global Investment Conference
September 9, 2025
1:30 PM ET
Webcast link One-on-one meetings
Please contact your conference representative to request one-on-one meetings.
Participants can view the presentations and replays by visiting the page of Emergent鈥檚 website.
About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we鈥檝e been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today鈥檚 health challenges and tomorrow鈥檚 threat, visit our聽聽and follow us on聽,听,听,听听补苍诲听.
Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
听听
Media Contact:
Assal Hellmer
Vice President, Communications
FAQ
When is Emergent BioSolutions (EBS) presenting at the Wells Fargo Healthcare Conference 2025?
When is EBS presenting at the HCW Global Investment Conference 2025?
How can investors access Emergent BioSolutions' conference presentations?
Will Emergent BioSolutions offer one-on-one meetings at these conferences?
